Experts speaking at the ADA’s Scientific Sessions supported making CGMs more accessible, but debated their usefulness for ...

Fruzaqla was licensed by Takeda from China's Hutchmed for $400 million upfront in 2023 and has also been approved in the US ...

The Acuvue Oasys Max 1-Day Multifocal marks the first and only daily disposable contact lens to be available for people with ...

Integra LifeSciences began 2025 with operational and supply chain headwinds that weighed on its performance, prompting a ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

Philips has launched a new point-of-care (POC) ultrasound system designed to broaden the accessibility of ultrasound for ...

ClearPoint shows strong fundamentals with growth potential from partner programs and treatment revenues in Huntington's and ...

Masimo Corporation refocuses on healthcare, projecting 8-11% growth by 2025. Click for why despite progress and solid ...

MSFT, NVDA and BAC shine in Zacks' top picks, with AI, cloud, and higher rates driving strong growth projections.

Mr. Trump’s action “basically is going to give a blanket opportunity around all the things that we need to turn back on this ...

Another BCMA-targeted agent has arrived for the treatment of multiple myeloma. | After a delay, Regeneron’s BCMA-directed ...